Directory · RU
Pharmaceutical Manufacturing in Russia
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Russia. Browse the public index, then filter or export on Kipplo.
Companies
135 on file
Synthon
Synthon is an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic medicines for patients around the world. Synthon's innovative R&D and proven ability to manufacture and distribute high-quality pharmaceuticals position the company well for the future. We work to develop therapies that address the needs of people worldwide and help improve their health and well-being. Through the provision of high-quality generic medicines, we make treatments more affordable and increase access to important remedies. Currently, our products are approved by regulatory agencies in more than 90 countries and marketed through strategic partnerships and – in dedicated areas – through direct sales. Synthon’s head office is based in Nijmegen, the Netherlands, and the company has affiliates in eight other countries. Synthon employs around 1,600 staff worldwide. In 2019, the company recorded a turnover of EUR 261 million. We are interested in result-oriented people with a sharp mind and entrepreneurial spirit, who can contribute to our ambition to provide solutions to the healthcare challenges of today and tomorrow. Interested in a new step in your pharma career? We would like to get to know you! For more information, go to In case your comment to one of our posts is missing, please check out our guidelines on
1001 to 5000 staff
Valenta Pharmaceuticals
JSC Valenta Pharmaceuticals is in TOP-3 of Russian pharmaceutical producers. The company provides more than 30 medicines for efficient treatment in the following therapeutic areas: psychoneurology, urology, gastroenterology, and general practice. The key Company’s brands are Ingavirin, Grammidin, Trimedat, Phenotropil, Phenazepam, Pantocalcin, etc. There are also new medicines in the R&D pipeline and registration process. Valenta has got its own production spot in Schelkovo (Moscow region). This allows implementing complicated manufacturing projects. Also, the Company is building a new plant to be opened in 2016 in the same area. All equipment for the new plant is being manufactured in Europe using state-of-the-art technologies. It will make this enterprise one of the most advanced production spots in Russian pharmaceutical market. The new plant will operate in strict accordance with GMP standards. Being a socially-responsible company, Valenta stands for responsible healthcare solutions for patients and doctors by providing them with great medicines. Company employs over 1300 people all over Russia. We are working as one team to develop Russian healthcare system and innovative medical science. All the employees are offered to have an attractive compensation package that includes competitive salary, annual bonuses, corporate transport, mobiles’ coverage, medical insurance and etc. Also, there are different educational and motivation programs for people development at all corporate levels. High expansion rate of our business gives our employees great opportunities for dynamic career growth. Our corporate culture is based on the values of respect, openness and transparency. We invite you to become a member of our team!
1001 to 5000 staff
Novartis
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at See our community guidelines: https://go.novartis.social/3Nboxki
10001+ staff
Piramal Critical Care
Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is a leader in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business.*RTU Ready to use Please note that adverse effects for any of our products should be reported to: medical.information@piramal.com
201 to 500 staff
R-Pharm
R-Pharm – Russian high-tech pharmaceutical enterprise, successfully transformed from distribution to a fully vertically integrated specialty pharma player. Founded in 2001 in Moscow, fully private; Employs over 3500 highly qualified specialists, has 50+ branches at 9 countries; Products from a broad number of therapeutic areas in specialty/hospital care; RUR 74,1 B revenue in 2015. Key areas of R-Pharm’s competence include: manufacturing of finished drugs and APIs, R&D of innovative medicines and technologies, training and education for industry and health care specialists, venture investments in promising scientific data and research, cooperation with major international pharmaceutical companies and international universities in the field of drug development and combined clinical trials in Russia. Since foundation not less than 85% of profits reinvested into infrastructure and products development. R-Pharm group’s mission is to contribute to professional advancement of healthcare specialists, to bring affordable efficient pharmaceutical products to patients, ensure the product quality at each R&D and production level and encourage the innovative approach in healthcare problems solving.
5001 to 10000 staff
Protek
НАША МИССИЯ «Протек – национальная Компания, заботящаяся о здоровье нации путем обеспечения населения товарами и услугами в сфере здоровья и красоты. Мы формируем высокие стандарты ведения бизнеса и инновационные технологии, создавая новые возможности для развития сотрудников, партнеров, коллег, инвесторов»
5001 to 10000 staff
Atlant Clinical
Atlant Clinical is an independent international contract research organization (CRO) offering a full range of clinical trials (Phases I-IV) and relevant support services throughout Europe, Russia, the CIS, and Baltics States. Quality of our work is confirmed by ISO 9001: 2015 certification by Bureau Veritas, as well as by numerous independent and client audits. We have a strong expertise across all major therapeutical areas and are fully capable of successfully executing even the most challenging and demanding clinical trials.
51 to 200 staff
Quantum Pharmaceuticals
Quantum Pharmaceuticals is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services and pursue in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and oncological efficacy.
11 to 50 staff
Nita-Farm
Nita-Farm is the leading developer and manufacturer of innovative professional veterinary medications. The Company has been the leader with the market of the post-Soviet states among the manufacturers of chemotherapeutic drugs for farm animals. Company’s mission To make highly-efficient and professional veterinary pharmaceuticals available.
201 to 500 staff
Llc Evapharm
A young, dynamically developing pharmaceutical company EVApharm is engaged in a full cycle of moving innovative products – from the production site until the appointment of a patient. Our mission is to assist patients in obtaining practical health most full range of diagnosis, prevention and treatment of innovative methods and treatment of socially significant diseases, leading to possible improvements in the demographic, economic and social situation in the Russian Federation. Task of the company is providing manufacturers promising and innovative medicines and diagnostic tools complete package of services on promotion: production of finished pharmaceutical products and diagnostic tools, distribution, working with doctors, researchers and the Administration to introduce innovative approaches in practical public health. Молодая, динамично развивающаяся фармацевтическая компания ЭВАфарм, ее род деятельности: полный цикл продвижения инновационных продуктов – от организации производственной площадки до назначения пациенту. Задачей компании является предоставление производителям перспективных и инновационных лекарственных препаратов и диагностических средств полного пакета услуг по продвижению: выпуск готовых лекарственных препаратов и диагностических средств, дистрибьюция, работа с врачебной аудиторией, научными работниками и администрацией по внедрению инновационных подходов в практическое здравоохранение.
11 to 50 staff
Nanolek
Nanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bioeconomy and amplifying the country’s biosafety. Nanolek’s product portfolio is formed in compliance with the priority therapeutic areas: cardiological and oncological products, innovative vaccines, including the cell-based influenza vaccine and the first Russian inactivated polio vaccine. In the meantime the company is also developing a number of biotech products, including new to the Russian market modern vaccines.
501 to 1000 staff
Otcpharm
OTCPharm — is a major company on the Russian OTC market in terms of the range of pharmaceuticals in the main therapeutic categories. Feedback We are always glad to make our work even better. And always ready to answer your questions. Ask a question The Company was spun off from Pharmstandart at the end of 2013. OTCPharm currently holds the exclusive rights for more than 250 trademarks. The Company`s portfolio includes well-known brands: Arbidol®, Pentalgin®, Complivit®, Flucostat®, Aphobazolum®, Codelac®, Amixin®, Acipol®, Maxicold®, Rhinostop®, Magnelis® B6, Noopept®, Asvitol®, Ascophenum-P®, Next®, Lactazar®, Selmevit®, Termicon®, Lactonorm®, Cyclovita®, Cinocap®, Univit®, Nitrocor®, Neosmectin®, Klarisens®, Azitrox®, Gastrozol®, Mycoderil®, Escape®, Uronorm®, Aerovit® and Spasmol®. Along with promoting proprietary brands, OTCPharm is engaged in marketing and promoting drugs whose trademarks are owned by third parties. These products allow the Company to develop expertise in the respective categories. The company’s mission Our mission is to promote public health and a higher quality of life in the country. We employ advanced approaches and innovative solutions to develop medicines which are intended to enhance health and well-being. We aim to make pharmaceuticals safe and available for all who need them.
1001 to 5000 staff
Paramed
A leader in bringing research-based medical products to Russia since 1993. Acts as a sole importer of several leading brands in Russia and CIS such as Mustela, Holtsch Medizin, Warwick Sasco, Becker-Manicure, Pro-lab Diagnostics and more. In addition Paramed is a distributor for Novartis, Merck Sharp & Dohme, Pfizer, GlaxoSmithKline, Life Scan, J&J Medical products.
51 to 200 staff
Promomed
PROMOMED Public joint-stock company is a leading innovative biopharmaceutical com-pany with attractive growth potential in promising segments of the pharmaceutical market. The Company has unique R&D Hub and manufacturing plant named BIOKHIMIK. This al-lows PROMOMED to develop innovative medicines, benefit from a full production cycle based on “From Idea, to Molecule, to Patient” concept, be fast in responding to unmet needs in healthcare, implement up-to-date technology solutions. PROMOMED is ranked #1 in Obesity treatment segment being an expert in metabolic health therapy. The Company is #1 in Russia in terms of the number of clinical trials and medical studies in 2022-2023.The Company is among TOP-3 in the relevant market segments in Onco, Antibiotics, HIV, Hepatitis. PROMOMED has a diversified portfolio of more than 330 medicines and is represented in all TOP-10 of the biggest and fastest growing therapeutic areas in the local market, such as On-co, Diabetes, Obesity, Neuro, Rheuma, Pain, etc. More than 80% of PROMOMED products are listed as live-saving products in the local Essential Drug List (EDL). The main drivers in the Com-pany's products range are branded pharmaceutical blockbusters, biotech products, innovative small molecules, as well as OTC brands. The state-of-the-art R&D Hub underpins advanced healthcare solutions and creates a solid background for business development. In addition to laboratories and centers for the develop-ment of Biotech and Small molecules, R&D Hub develops active drug substances, ensures regis-tration service, technology transfers and production scaling, leads market authorization and sup-ports the development of advanced Quality controls methods. The Company’s deep expertise in the field of innovative chemical technologies and Bio-tech, combined with modern manufacturing plant, allow PROMOMED to occupy leading positions in various professional ratings and ensure her active and important contribution to local Healthcare system
1001 to 5000 staff
Ipharma Cro
IPHARMA, the partner of "Skolkovo" Innovative Center, is a fast-growing CRO in Russia and EAEU. Our mission is to contribute to progress of treating patients with socially significant and other important diseases by efficient organization of clinical studies and introduction of novel drugs to medical practice. Our pipeline consists of over 150 clinical studies in various therapeutic areas including oncology, HIV, HCV, diabetes, bronchial asthma, rheumatoid arthritis, schizophrenia, Alzheimer's disease and many others. We provide efficient clinical trial solutions in both early-phase and registration studies, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug development and market access. According to Association of Clinical Trial Organizations (ACTO), IPHARMA has been ranked as a top Russian CRO (ACTO Analytical reports 2013-2018). Advantages of working with IPHARMA: 1. Full-service CRO + study design, medical writing,+ regulatory, project management, logistics + site management, patient recruitment, monitoring,+ DM, biostats, medical monitoring,+ MAA, PV, QA. Internal medical expertise and access to KOLs 3. Shortest timelines guaranteed 4. Qualified clinical staff + MD / PharmD / MSc,+>20% PhD,+ 8 years in clinical research on average. Quality management system in accordance with ICH GCP & GVP.
51 to 200 staff
Petrovax Pharm
Petrovax is a company of novel biopharmaceutical practices with 28 years of successful experience. The product portfolio includes original pharmaceutical products and vaccines, biotechnology drugs, branded generics and food supplements. Petrovax is the holder of patents for molecules and pharmaceutical manufacturing technologies in Russia and abroad. Its own R&D center for pre-clinical studies enables a full cycle of drug development. Petrovax’s modern manufacturing complex in the Moscow Region operates in full compliance with the EAEU and EU GMP standards. The synthesis of APIs, sterile and non-sterile pharmaceutical forms production is performed at the manufacturing complex. The annual production capacity is 160 million doses. The company is one of the largest Russian exporters of original medicinal products and vaccines, which are supplied to EAEU and EU countries. Petrovax is a partner of international Big Pharma companies: Pfizer, Abbott, ISU ABXIS, Adimmune, Hengrui. The development strategy focuses on providing patients with in-demand vaccines and medicines for the prevention and treatment of socially significant conditions, such as infectious, oncological, and orphan diseases. Petrovax has over 700 employees. The company's vision:"Leading pharmaceutical innovations". Our mission:"Expanding access to cutting-edge therapies".
501 to 1000 staff
Pharmline Llc
n 1992, we started as a small multi-specialty company operating in the Moscow pharmaceutical market. Today, PharmLine offers a wide range of hospital products, medical devices and vaccines from the leading Global and Local companies. We supply them to the Federal and Regional health authorities, institutional clients, charitable foundations, and also to the many hospitals and pharmacies in the Russian regions.
201 to 500 staff
Biocad
BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.
1001 to 5000 staff
Bright Way Group
Динамично развивающаяся группа компаний, стратегия развития которой, включает в себя реализацию значимых проектов в фармацевтической отрасли Российской Федерации. Velpharm — производственная фармацевтическая компания в городе Курган 2. Veltrade - торговая фармацевтическая компания, дистрибьютор готовых лекарственных препаратов и фармацевтических субстанций на территории РФ и СНГ 3. Bright Way LLC — фармацевтическая компания, осуществляющая внешнеэкономическую деятельность 4. Bright Way Industries — новая производственная площадка (Зеленоград). Введение в эксплуатацию – 2021 год
501 to 1000 staff
Esko Pharma
ESKO PHARMA is a private pharmaceutical company was established in 2005. We specialize in promotion of Rx pharmaceutical products in therapeutic areas such as neurology, cardiology and vascular surgery. ESKO PHARMA operates in 39 cities and works on further expanding to provide original medicines and high-quality generic medicines to patients across the Russian Federation. Please get in touch if you are interested in a product promotion on an exclusive basis to discuss future cooperation.
11 to 50 staff
Invar
1st Choice Partner for out-licensing Your Innovative Products in Russia INVAR is a national pharmaceutical company forming its product portfolio of innovative products on the basis of long-term exclusive in-licensing agreements for the Russian market
51 to 200 staff
Non-Commercial Partnership Equal Right To Life
EQUAL RIGHT TO LIFE was created to develop, introduce and implement non-commercial projects that aimed to increase access to innovative anti-cancer and critical diseases treatments. The major scope of activities- special education programs for healthcare professionals - cancer awareness campaigns - patients' advocacy programs - partnering with the state institutions and authorities - developing new economic and operational approaches in the healthcare management
11 to 50 staff
Statandocs
Statandocs provides medical writing, data management and biostatistics services for pharmaceutical companies, individual investigators/developer and contract research organzations (CROs). Our employees have profound knowledge of preclinical and clinical studies with industry experience as principal investigators or sub-investigators, study coordinators, clinical research associates, data managers, project manages and clinical team leaders. Statandocs has broad network of consultants including key opinion leader (KOLs).
51 to 200 staff
Alfa-Lab Company
Cleaning and safety products for cleanroom and food industries
51 to 200 staff
